Category: ori investigations

Retraction Watch readers are likely familiar with the U.S. Office of Research Integrity (ORI), the agency that oversees institutional investigations into misconduct in research funded by the NIH, as well as focusing on education programs.

Earlier this month, ORI released data on its case closures dating back to 2006. We’ve charted those data in the graphics below. In 2021, ORI made just 3 findings of misconduct, a drop from 10 — roughly the average over the past 15 years — in 2020. Such cases can take years.

As the first chart makes clear, a similar dip in ORI findings of misconduct occurred in 2016. That was then-director Kathy Partin’s first year in the role, and a time of some turmoil at the agency. In an interview with us then, Partin referred multiple times to the agency being short-staffed. Partin was removed from the post in 2017 and became intramural research integrity officer at the NIH in 2018.

ORI — as has often been the case over the past two decades — is once again without a permanent director. The most recent permanent director, Elisabeth (Lis) Handley, became Principal Deputy Assistant Secretary for Health in the Office of the Assistant Secretary for Health in July 2021.

We asked ORI to explain what’s behind the figures. A spokesperson responded on their behalf.

Continue reading A U.S. federal science watchdog made just three findings of misconduct in 2021. We asked them why.

If you file public records requests regularly, you have likely become used to how long they can take, and how few documents you may end up with. We certainly have. But we’re prompted to share a particularly frustrating experience with the NIH.

Settle in. This is a three-and-a-half year tale — and counting.

On May 8, 2018, we made a public records request to the NIH under the Freedom of Information Act for “Any Correspondence between the Office of Policy for Extramural Research Administration (OPERA) and officials at Duke University during the month of March 2018.” We did so because, as we reported on March 23, 2018 in Science, the NIH had:

Continue reading HHS takes three and a half years to tell us “there are no records responsive to your request”…for a letter we know exists

A cancer researcher who was a former division director at Emory University in Atlanta “engaged in research misconduct by knowingly, intentionally, and/or recklessly falsifying data” in a federal grant application and six published papers, according to new findings from the U.S. Office of Research Integrity.

Ya Wang, who retired from Emory a year ago, “falsified protein immunoblot data by reusing and relabeling the same images to represent different experimental conditions in mammalian tissue culture models of DNA damage and repair in eighteen (18) figure panels in eleven (11) figures in one (1) grant application and six (6) published papers,” the ORI said.

Wang “neither admits nor denies” ORI’s findings of misconduct, according to the agency’s report on the case. She agreed to a four-year ban on any federal funding, and to correct or retract four papers:

Continue reading Former Emory division director committed misconduct, says federal watchdog

A former researcher at the Mount Desert Island Laboratory in Maine who co-founded a lab spinoff faked data in research supported by federal funding, according to the U.S. Office of Research Integrity.

The researcher, Viravuth Yin, “engaged in research misconduct by knowingly, intentionally, and/or recklessly falsifying and/or fabricating data,” the ORI said in an announcement about the case. The work was published and submitted from 2015 to 2019, and Yin was principal investigator on one of the grants named by the ORI, worth more than $900,000.

Continue reading Biotech co-founder faked data in NIH-funded research, says federal watchdog

A cancer researcher once involved in a federal research integrity probe has repeatedly been denied funding and other sources of income, according to his attorney, who blamed our coverage of the case for the scientist’s continuing woes and asked us to remove a post.  

[Please see an update on this post.]

Our coverage of the work of Sam W. Lee goes back to 2013. But it was our reporting in April 2019 that Lee — once a member of the Harvard faculty — was the subject of an investigation by the U.S. Office of Research Integrity that was the subject of the attorney’s letter. ORI has yet to announce a conclusion in its inquiry, which appears to have reached a finding before we posted on the matter. He has at least five retractions — including two that appeared after April 2019 — and two expressions of concern. 

One of those expressions of concern was for a 2000 paper in Molecular and Cellular Biology titled “Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression.”

The disposition of that article, published by the American Society for Microbiology, like the ORI inquiry, remains unclear. 

In a letter dated August 12, attorney Steven Seinberg, who is based in Los Angeles, claimed that since our April 2019 post, Lee has struggled both personally and professionally:

Continue reading Attorney asks Retraction Watch to remove post because client has lost out on opportunities

The U.S. Office of Research Integrity, which oversees investigations into allegations of misconduct in grants from the NIH, is once again without a permanent director.

Elisabeth (Lis) Handley, who became director in 2019, has taken on a new role in the U.S. Department of Health and Human Services (HHS), of which ORI is a part. Wanda Jones, who has served as interim and deputy director of the agency, will serve as acting director, according to an HHS spokesperson.

Handley has become principal deputy assistant secretary for health. In a memo to staff, assistant secretary for health Rachel Levine wrote:

Continue reading US federal watchdog loses director to another government role

A former postdoc at the University of Texas Health Science Center has been found guilty of misconduct stemming from efforts to rig preprint servers to boost the postdoc’s publication metrics.

The findings about Yibin Lin include the fabrication and falsification of data, as well as plagiarism in six published papers that have since been retracted from the preprint server bioRxiv. On none of those articles does the name “Yibin Lin” appear as an author.

Lin also admitted to making up author names on submitted articles — none of which was published — to dupe preprint servers to “improve his citation metrics,” according to the U.S. Office of Research Integrity (ORI).

Continue reading Former Texas postdoc earns 10-year federal funding ban for faking authors and papers to boost metrics

A pharmacologist at the University of Texas Southwestern Medical Center who lost a highly cited 2014 paper in Nature for questions about the integrity of her data has been sanctioned by the U.S. Office of Research Integrity (ORI) — and UT Southwestern has rescinded two professorships she previously held.

According to ORI, Yihong Wan, an associate professor of pharmacology at UT Southwestern: 

Continue reading Texas bone researcher faked data in Nature paper, says federal watchdog, as university rescinds professorships

An associate dean at the University of Miami stepped down from his post two weeks after agreeing to sanctions stemming from a finding of misconduct by a government watchdog, Retraction Watch has learned.

Yesterday, we reported that the U.S. Office of Research Integrity (ORI) found that Charles Downs, “engaged in research misconduct by intentionally, knowingly, or recklessly falsifying and/or fabricating data” in six federal grant applications while on the faculty of the University of Arizona.

Downs was appointed associate dean of Miami’s nursing school in 2018, and stepped down from the position on December 4, according to a university spokesperson. He remains an associate professor at the school.

Continue reading Miami dean stepped down weeks after misconduct finding

A former researcher at the University of Arizona who is now was until last week an associate dean at the University of Miami “engaged in research misconduct by intentionally, knowingly, or recklessly falsifying and/or fabricating data” in six federal grant applications, according to a new finding by the U.S. Office of Research Integrity (ORI).

Charles A. Downs’ work “focuses on acute lung injury and pulmonary diseases,” according to a 2018 press release from the University of Miami announcing his appointment. He “neither admits nor denies ORI’s findings of research misconduct,” the ORI announced today. The agency said that Downs

Continue reading Researcher, until last week a Miami dean, faked data in grant applications, says federal watchdog